1
|
Wang X, Gu L, Zhang Y, Sargent DJ, Richards W, Ganti AK, Crawford J, Cohen HJ, Stinchcombe T, Vokes E, Pang H. Validation of survival prognostic models for non-small-cell lung cancer in stage- and age-specific groups. Lung Cancer 2015; 90:281-7. [PMID: 26319317 DOI: 10.1016/j.lungcan.2015.08.007] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2015] [Revised: 07/03/2015] [Accepted: 08/13/2015] [Indexed: 01/16/2023]
Abstract
PURPOSE Prognostic models have been proposed to predict survival for non-small-cell lung cancer (NSCLC). It is important to evaluate whether these models perform better than performance status (PS) alone in stage- and age-specific subgroups. PATIENTS AND METHODS The validation cohort included 2060 stage I and 1611 stage IV NSCLC patients from 23CALGB studies. For stage I, Blanchon (B), Chansky (C) and Gail (G) models were evaluated along with the PS only model. For stage IV, Blanchon (B) and Mandrekar (M) models were compared with the PS only model. The c-index was used to assess the concordance between survival and risk scores. The c-index difference (c-difference) and the integrated discrimination improvement (IDI) were used to determine the improvement of these models over the PS only model. RESULTS For stage I, B and PS have better survival separation. The c-index for B, PS, C and G are 0.61, 0.58, 0.57 and 0.52, respectively, and B performs significantly better than PS with c-difference=0.034. For stage IV, B, M and PS have c-index 0.61, 0.64 and 0.60, respectively; B and M perform significantly better than PS with c-difference=0.015 and 0.033, respectively. CONCLUSION Although some prognostic models have better concordance with survival than the PS only model, the absolute improvement is small. More accurate prognostic models should be developed; the inclusion of tumor genetic variants may improve prognostic models.
Collapse
Affiliation(s)
- Xiaofei Wang
- Department of Biostatistics & Bioinformatics and Alliance Statistics and Data Center, Duke University, Durham, NC, United States.
| | - Lin Gu
- Department of Biostatistics & Bioinformatics and Alliance Statistics and Data Center, Duke University, Durham, NC, United States
| | - Ying Zhang
- Department of Biostatistics & Bioinformatics and Alliance Statistics and Data Center, Duke University, Durham, NC, United States
| | - Daniel J Sargent
- Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN, United States
| | | | - Apar Kishor Ganti
- Department of Internal Medicine, VA Nebraska Western Iowa Health Care System and University of Nebraska Medical Center, Lincoln, NE, United States
| | - Jeffery Crawford
- Department of Medicine, Duke University Medical Center, Durham, NC, United States
| | - Harvey Jay Cohen
- Department of Medicine, Duke University Medical Center, Durham, NC, United States
| | - Thomas Stinchcombe
- Department of Medicine, University of North Carolina, Chapel Hill, NC, United States
| | - Everett Vokes
- Department of Medicine, University of Chicago, Chicago, IL, United States
| | - Herbert Pang
- Department of Biostatistics & Bioinformatics and Alliance Statistics and Data Center, Duke University, Durham, NC, United States; School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
| |
Collapse
|